Funded Tech Companies

Aileron Therapeutics

Wondering who invested in Aileron Therapeutics? SR One Capital Management, Lilly Ventures and Roche Venture Fund put venture money into this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Aileron Therapeutics (NASDAQ: ALRN) is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/28/2017

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Manuel Aivado

        

Chief Financial Officer

Donald Dougherty

        

Chief Medical Officer

Vojislav Vukovic

        

VP - Bus. Development

Kathryn Gregory

        

VP - R & D

Allen Annis

        

Company Investors

• SR One Capital Management (Michael Diem)
• Lilly Ventures
• Roche Venture Fund
• Novartis Venture Fund (Campbell Murray)
• Excel Venture Management (Enrico Petrillo)
• Apple Tree Partners (Seth Harrison)
• AJU IB Investment
• GlaxoSmithKline
• Excel Medical Fund (Enrico Petrillo)
• Novartis BioVenture Fund (Campbell Murray)

Browse more funded tech companies:

Aila Technologies | Aily Labs

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary